EDGAR Filing Documents for 0001410578-23-000844

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:

SEC Accession No. 0001410578-23-000844

Filing Date

2023-04-28

Accepted

2023-04-28 17:30:31

Documents

106

Period of Report

2022-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	20-F	tmb-20221231x20f.htm iXBRL	20-F	3235282
2	EX-4.18	tmb-20221231xex4d18.htm	EX-4.18	201546
3	EX-4.26	tmb-20221231xex4d26.htm	EX-4.26	77922
4	EX-11.1	tmb-20221231xex11d1.htm	EX-11.1	49769
5	EX-12.1	tmb-20221231xex12d1.htm	EX-12.1	11868
6	EX-12.2	tmb-20221231xex12d2.htm	EX-12.2	12207
7	EX-13.1	tmb-20221231xex13d1.htm	EX-13.1	5680
8	EX-13.2	tmb-20221231xex13d2.htm	EX-13.2	5668
9	EX-15.1	tmb-20221231xex15d1.htm	EX-15.1	493631
10	EX-15.2	tmb-20221231xex15d2.htm	EX-15.2	81840
11	EX-15.3	tmb-20221231xex15d3.htm	EX-15.3	2870
12	GRAPHIC	tmb-20221231x20f001.jpg	GRAPHIC	34470
13	GRAPHIC	tmb-20221231x20f002.jpg	GRAPHIC	47256
14	GRAPHIC	tmb-20221231x20f003.jpg	GRAPHIC	15148
15	GRAPHIC	tmb-20221231x20f009.jpg	GRAPHIC	21654
16	GRAPHIC	tmb-20221231xex11d1001.jpg	GRAPHIC	9656
17	GRAPHIC	tmb-20221231xex15d1001.jpg	GRAPHIC	5441
18	GRAPHIC	tmb-20221231xex15d2001.jpg	GRAPHIC	9662
	Complete submission text file	0001410578-23-000844.txt		11460802

Data Files

Seq	Description	Document	Type	Size
19	EX-101.SCH	tmb-20221231.xsd	EX-101.SCH	99319
20	EX-101.CAL	tmb-20221231_cal.xml	EX-101.CAL	53355
21	EX-101.DEF	tmb-20221231_def.xml	EX-101.DEF	246804
22	EX-101.LAB	tmb-20221231_lab.xml	EX-101.LAB	525936
23	EX-101.PRE	tmb-20221231_pre.xml	EX-101.PRE	434759
100	EXTRACTED XBRL INSTANCE DOCUMENT	tmb-20221231x20f_htm.xml	XML	1646316

Mailing Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5

Business Address SUITE 2400 - 745 THURLOW STREET VANCOUVER A1 V6E 0C5 403-607-2621

XORTX Therapeutics Inc. (Filer) CIK: 0001729214 (see all company filings)